Eperisone Safety During Breastfeeding
Eperisone should be avoided during breastfeeding due to complete absence of safety data on breast milk excretion and infant exposure.
Evidence Assessment
The provided evidence contains no information whatsoever about eperisone use during lactation. Despite reviewing multiple comprehensive guidelines on breastfeeding safety 1, authoritative pediatric guidelines 2, and research on medication safety during lactation 3, 4, 5, 6, 7, eperisone is not mentioned in any lactation safety resource.
The FDA drug label information provided 8 appears to be for a combination analgesic product containing acetaminophen and aspirin—not eperisone—and is therefore irrelevant to this question.
Clinical Reasoning
Why Eperisone Cannot Be Recommended:
- No pharmacokinetic data on breast milk transfer exists
- No infant safety data has been published
- No established relative infant dose (RID) calculations available
- Eperisone is a centrally-acting muscle relaxant with unknown biochemical mechanisms 9, 10
- The drug acts on the central nervous system, raising theoretical concerns about infant neurodevelopmental effects
Key Principles from Lactation Guidelines:
When evaluating medication safety during breastfeeding, the 2020 Association of Anaesthetists guideline 1 emphasizes that drugs should only be used when:
- Transfer into breast milk is documented as minimal
- Oral bioavailability in infants is poor
- Clinical experience demonstrates safety
Eperisone meets none of these criteria.
Practical Recommendation
Use alternative muscle relaxants with established lactation safety profiles:
- For muscle spasm/pain: Ibuprofen or diclofenac (extensively studied, safe during breastfeeding) 1
- For severe pain: Morphine (recommended opioid of choice if strong analgesia needed) 1
- For musculoskeletal conditions: Physical therapy, acetaminophen (safe, well-studied) 1
Critical Caveats
- The absence of reported adverse effects does not equal safety—it reflects lack of study 6
- Eperisone is primarily used in Korea and Japan 9, limiting global pharmacovigilance data
- The drug has documented immediate hypersensitivity reactions including anaphylaxis 9, adding another safety concern
- Most psychotropic and centrally-acting drugs require specific lactation studies before recommendation 7
If eperisone is deemed absolutely necessary, the mother should be counseled to discontinue breastfeeding until treatment is complete, as the risk-benefit analysis cannot be performed without basic safety data.